Complete remission obtained with azacitidine in a patient with concomitant therapy related myeloid neoplasm and pulmonary mucormycosis

Medicine and Dentistry

• Patient 100%
• Mucormycosis 75%
• Spontaneous Remission 75%
• Infection 75%
• Acute Myelogenous Leukemia 75%
• Diseases 50%
• Combination Therapy 50%
• Antileukemic Agent 50%
• Azacitidine 50%
• Therapeutic Procedure 50%
• Pneumonia 25%
• Leukemia 25%
• Mycosis 25%
• Neutropenia 25%
• Neoplasm 25%
• Diagnosis 25%
• Prognostic Factor 25%
• General Condition 25%
• Fatality 25%
• Antifungal Therapy 25%
• Amphotericin B 25%
• Antifungal Agent 25%
• Candidiasis 25%
• Aspergillosis 25%
• Systemic Mycosis 25%
• Posaconazole 25%
• Anti-Infective Therapy 25%
• Incidence 25%
• Healing 25%
• Comprehension 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Remission 75%
• Infection 75%
• Mucormycosis 75%
• Diseases 50%
• Azacitidine 50%
• Neoplasm 25%
• General Condition 25%
• Neutropenia 25%
• Amphotericin B 25%
• Mycosis 25%
• Candidiasis 25%
• Fatality 25%
• Leukemia 25%
• Pneumonia 25%
• Posaconazole 25%
• Systemic Mycosis 25%
• Incidence 25%
• Healing 25%
• Aspergillosis 25%